Julio Licinio: Asset Of The Medical World
As depression is a leading cause of disability across the globe, Professor Julio Licinio is moving a ‘trial and error’ approach to antidepressant treatment, where each patient is given the antidepressant that is best suited to them. He aims to match each genetic variation to the antidepressant that will be most effective for people facing depression.

Professor Julio Licinio is a Matthew Flinders established Professor of Psychiatry at Flinders University, Adelaide. He is also a Clinical Professor of Psychiatry at the University of Adelaide, Adelaide and University of New Mexico School of Medicine, Albuquerque; Adjunct Professor of Psychiatry, University of Texas Health Science Center, Houston; and visiting Professor of Psychiatry, University of Minho, Braga, Portugal.
Professor Julio’s research area was mainly on Molecular Medicine, Genetics, Genomics, Endocrinology, Psychiatry (Incl. Psychotherapy) and Neurogenetics. His research on the essential endocrine and pharmacogenomic mechanisms at the line of obesity and depression have gained a noticeable name in scientific literature. He achieved the position of chief editor of three Nature Publishing Group journals: The Pharmacogenomics Journal, Translational Psychiatry and Molecular Psychiatry.
He is a big innovator in the medical world. Apart from being the Deputy Director, Mind and Brain Theme (SAHMRI), he has an amazing professional profile. He is a:
- Strategic Professor of Psychiatry at Flinders University
- Editor and Translational Psychiatry in Nature Publishing Group
- Editor and Pharmacogenomics Journal Nature Publishing Group
- Editor, Molecular Psychiatry Nature Publishing Group.
He also worked as a Director in John Curtin School of Medical Research, Australian National University for 4 years, Miller Professor of Psychiatry University of Miami, Miller School of Medicine for 3 years, Chairman of Psychiatry, Associate Dean for Project Development, Professor of Psychiatry & Bio-behavioral Sciences and Medicine/Endocrinology in UCLA for 7 years among others.
He also actively managed some major roles at University of California, Los Angeles too:
- Vice-Chairman, Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine.
- Associate Program Director, General Clinical Research Center
Founding Co-Director, Center for Pharmacogenomics. - Founding Director, Graduate Training Program in Translational and Clinical Investigation.
- Founding Director, Mentored Clinical Pharmacology Research Scholars Program.
- Founding Director, UCLA Clinical Pharmacology Training Program
Recently he is working on various projects, mainly on, Effects of leptin replacement therapy in congenital leptin deficiency and Obesity: Underpinning Genetic Etiology. Through various social media and books he actively spread about his researches, so that people can be aware of various medical condition related to brain and mind.
